Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
October 24, 2005
- DIAGNOSTIC NEWS IN BRIEF
October 24, 2005
- Medical Fees Must Be Raised for Better Healthcare: JMA President
October 17, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 17, 2005
- FPMAJ Opposes More Frequent NHI Price Revisions
October 17, 2005
- 1,636 Organ Transplants in Japan Since 1995
October 17, 2005
- Safety Div. to Monitor Drug Information Supply by Companies
October 17, 2005
- JPMA to Revise Its Promotion Code
October 17, 2005
- REGULATORY NEWS IN BRIEF
October 17, 2005
- Takeda to Take the Offensive in Marketing Actos
October 17, 2005
- JGPMA Member Companies Report Overall Declines in Profits
October 17, 2005
- MCHC Created on Oct. 3 with MCC and MPC as Core Members
October 17, 2005
- BUSINESS NEWS IN BRIEF -1-
October 17, 2005
- BUSINESS NEWS IN BRIEF -2-
October 17, 2005
- SEMINAR
October 17, 2005
- Betaferon Protects against Progression to Multiple Sclerosis: Schering AG
October 17, 2005
- R&D NEWS IN BRIEF
October 17, 2005
- SURVEY 2 articles
October 17, 2005
- PMDA Monitors ADRs under Anticancer Combination Therapies
October 17, 2005
- New Chuikyo Starts Full Discussions
October 17, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…